Evaluation of bepridil for the treatment of angina pectoris: Evidence for preservation of left ventricular function

The efficacy of bepridil (400 mg once a day) was assessed in 15 patients with exertional angina pectoris. All 15 patients reported substantial clinical improvement during bepridil treatment compared with placebo treatment. Episodes of angina were 11.8 ± 4.1 (mean ± standard error of the mean)/ week...

Ausführliche Beschreibung